Abstract
Life-threatening bleeding can occur in non-hemophiliacs with factor VIII inhibitor and is difficult to control. Various methods have been used to suppress the inhibitor. Since 1993 we treated 6 non-hemophilic patients with factor VIII inhibitor with cyclophosphamide, vincristine, and prednisone (CVP) every 3-4 weeks. Five had complete response with disappearance of factor VIII inhibitor and normalization of factor VIII after 1 to 7 cycles of CVP. One patient did not respond after 4 cycles of CVP; mitoxantrone was added to additional two cycles of CVP, and the inhibitor disappeared.
Copyright 2002 Wiley-Liss, Inc.
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Autoimmune Diseases / blood
-
Autoimmune Diseases / drug therapy*
-
Cyclophosphamide / administration & dosage
-
Cyclophosphamide / therapeutic use*
-
Drug Therapy, Combination
-
Factor VIII / analysis
-
Factor VIII / immunology*
-
Female
-
Humans
-
Immunosuppressive Agents / administration & dosage
-
Immunosuppressive Agents / therapeutic use
-
Male
-
Middle Aged
-
Prednisone / administration & dosage
-
Prednisone / therapeutic use*
-
Recurrence
-
Remission Induction
-
Vincristine / administration & dosage
-
Vincristine / therapeutic use*
Substances
-
Immunosuppressive Agents
-
Vincristine
-
Cyclophosphamide
-
Factor VIII
-
Prednisone